Whalegun
Home

Noah Goodman, Chief Business Officer: Kymera Therapeutics KYMR Sell · Filed 06/25

Trade details

Type
Insider sale
Amount
$272,500
Shares · price
2,500 sh · $109.00 a share
Held after
52,695.44 sh
Stock
Kymera Therapeutics KYMR
Person
Noah GoodmanChief Business Officer
Trade date
26/06/25
Filed
26/06/25
Days to filing
0 days

Sold 4.5% of holdings

Share of holding sold
4.5%

Kymera Therapeutics trades, last 26 weeks

What else happened in Kymera Therapeutics around then

Filed or reported within 30 days of the trade day · 05/26~07/25

Noah Goodman's recent trades

  • Noah Goodman

    Planned sale10b5-1 planKymera Therapeutics

    $388.6K

    Filed 07/01

  • Noah Goodman

    Sell10b5-1 planKymera Therapeutics

    $297.5K

    Filed 06/25

  • Noah Goodman

    Planned sale10b5-1 planKymera Therapeutics

    $499.4K

    Filed 06/25

  • Noah Goodman

    Sell10b5-1 planKymera Therapeutics

    $247.5K

    Filed 06/22

  • Noah Goodman

    Planned sale10b5-1 planKymera Therapeutics

    $226.1K

    Filed 06/22

Noah Goodman, Chief Officer — sold $272.5K of Kymera Therapeutics KYMR · 4.5% of holdings · 10b5-1 plan | Whalegun